Genenta Science S.p.A. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GNTA Nasdaq 2834 www.genenta.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genenta Science S.p.A.

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals - Jul 1st, 2025 3:00 am
Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference - May 8th, 2025 5:00 am
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies - May 7th, 2025 5:00 am
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - Apr 15th, 2025 3:00 am
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates - Mar 19th, 2025 7:28 am
February 2025 US Penny Stocks With Promising Prospects - Feb 17th, 2025 10:10 am
Is Genenta Science S.p.A. (GNTA) the Best Italian Stock to Buy in 2025? - Feb 12th, 2025 10:03 pm
TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - Jan 28th, 2025 6:01 am
3 Penny Stocks In US With Market Caps Below $300M - Jan 12th, 2025 5:10 pm
Genenta Science announces amendment to pact with AGC Biologics - Jan 10th, 2025 4:51 am
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - Jan 9th, 2025 4:00 am
ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - Jan 8th, 2025 1:17 pm
3 US Penny Stocks With Market Caps Over $30M To Consider - Nov 13th, 2024 10:05 am
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” - Oct 23rd, 2024 5:00 am
Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders - Oct 11th, 2024 5:35 am
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer - Oct 2nd, 2024 4:30 am
Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative Biotech - Sep 30th, 2024 3:12 am